Skip to playerSkip to main contentSkip to footer
  • 9/12/2018
The chief executive of Nostrum Pharmaceuticals recently described the 400% price hike of a drug classified as “essential” by the World Health Organization as being a “moral” obligation.

Category

🗞
News

Recommended